Trade

with

Bristol-Myers Squibb Co
(NYSE: BMY)
AdChoices
53.63
+1.13
+2.15%
After Hours :
53.68
+0.05
+0.09%

Open

52.56

Previous Close

52.50

Volume (Avg)

9.03M (5.84M)

Day's Range

52.48-54.36

52Wk Range

46.30-57.49

Market Cap.

88.91B

Dividend Rate (Yield )

1.44 (2.69%)

Beta

0.43

Shares Outstanding

1.66B

P/E Ratio (EPS)

33.22 (1.61)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 16.39B

    • Net Income

    • 2.56B

    • Market Cap.

    • 88.91B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 16.59

    • PEG (Price/Earnings Growth) Ratio

    • 1.97

    • Beta

    • 0.43

    • Forward P/E

    • 31.95

    • Price/Sales

    • 5.52

    • Price/Book Value

    • 5.80

    • Price/Cash flow

    • 21.60

      • EBITDA

      • 3.85B

      • Return on Capital %

      • 7.71

      • Return on Equity %

      • 18.10

      • Return on Assets %

      • 7.71

      • Book Value/Share

      • 9.24

      • Shares Outstanding

      • 1.66B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.36 (10/1/2014)

      • Dividend Declaration Date

      • 9/16/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 50.00

        • Credit Rating

        • AA-

        • Analysts

        • 5

        • EPS Estimate

        • 1.59

        • Cashflow Estimate

        • 1.99

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -3.90

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • 30.80

          • 7.80

          • Net Income

            Q/Q (last year)

          • -37.90

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -4.47

          • 6.10

          • Net Income

            5-Year Annual Average

          • -4.10

          • 3.73

          • Dividends

            5-Year Annual Average

          • 2.60

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 72.81

            • 69.92

            • Pre-Tax Margin

            • 19.25

            • 21.84

            • Net Profit Margin

            • 16.59

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 73.00

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 24.90

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 23.30

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.48

              • 0.32

              • Current Ratio

              • 1.80

              • 1.92

              • Quick Ratio

              • 1.31

              • 1.31

              • Interest Coverage

              • 16.68

              • 17.64

              • Leverage Ratio

              • 2.19

              • 2.03

              • Book Value/Share

              • 9.24

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 33.22

                • 22.99

                • P/E Ratio 5-Year High

                • 35.65

                • 193.96

                • P/E Ratio 5-Year Low

                • 13.44

                • 87.26

                • Price/Sales Ratio

                • 5.52

                • 3.84

                • Price/Book Value

                • 5.80

                • 3.83

                • Price/Cash Flow Ratio

                • 21.60

                • 14.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 88.68

                    • Dividend Date

                    • 9/16/2014

                    • Ex-Dividend Date

                    • 10/1/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 18.10

                        (30.60)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • 7.71

                        (13.80)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • 12.81

                        (21.80)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • 96.00k

                      • 90.07k

                      • Inventory Turnover

                      • 2.55

                      • 2.46

                      • Asset Turnover

                      • 0.46

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      3.10B
                      Operating Margin
                      18.90
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      21.60
                      Ownership

                      Institutional Ownership

                      71.74%

                      Top 10 Institutions

                      31.64%

                      Mutual Fund Ownership

                      39.64%

                      Float

                      99.88%

                      5% / Insider Ownership

                      0.30%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Health Care Fund

                      •  

                        36,197,961

                      • 22.96

                      • 2.18

                      • VA CollegeAmerica Income Fund of America

                      •  

                        31,722,500

                      • -3.62

                      • 1.91

                      • Vanguard Total Stock Mkt Idx

                      •  

                        27,125,799

                      • 0.79

                      • 1.64

                      • Vanguard Five Hundred Index Fund

                      •  

                        17,211,971

                      • 0.28

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        16,796,307

                      • -1.01

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        16,539,310

                      • 1.43

                      • 1.02

                      • VA CollegeAmerica Washington Mutual

                      •  

                        16,345,400

                      • 0.00

                      • 0.99

                      • Vanguard Wellington™

                      •  

                        13,804,990

                      • 32.97

                      • 0.83

                      • BlackRock Equity Dividend Fund

                      •  

                        9,989,070

                      • -1.75

                      • 0.60

                      • VA CollegeAmerica American Balanced

                      •  

                        9,950,000

                      • -10.76

                      • 0.60

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wellington Management Company, LLP

                      •  

                        119,946,967

                      • +34.52%

                      • 7.23

                      • Vanguard Group, Inc.

                      •  

                        84,156,909

                      • +2.40%

                      • 5.08

                      • Capital World Investors

                      •  

                        78,445,860

                      • -2.94%

                      • 4.73

                      • State Street Corp

                      •  

                        66,436,040

                      • +1.86%

                      • 4.01

                      • BlackRock Fund Advisors

                      •  

                        53,562,962

                      • +5.19%

                      • 3.23

                      • Fidelity Management and Research Company

                      •  

                        31,576,762

                      • -28.97%

                      • 1.90

                      • J.P. Morgan Investment Management Inc.

                      •  

                        25,406,144

                      • -0.17%

                      • 1.53

                      • Northern Trust Investments, N.A.

                      •  

                        24,628,793

                      • -0.10%

                      • 1.49

                      • Jennison Associates LLC

                      •  

                        23,675,401

                      • -18.42%

                      • 1.43

                      • T. Rowe Price Associates, Inc.

                      •  

                        16,744,454

                      • -5.15%

                      • 1.01

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Slow Growth

                      Style

                      Large Growth

                      Bristol-Myers Squibb Co, a Delaware corporation was incorporated in August 1933 under the name Bristol-Myers Company. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. It is a bi...moreopharmaceutical company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company operates in one segment: Biopharmaceuticals. The Company’s pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes (typically involving recombinant DNA technology), called ‘biologics’. Small molecule drugs are typically administered orally, e.g., in the form of a pill or tablet, although other drug delivery mech...moreanisms are used as well. Biologics are typically administered to patients through injections or by infusion. Its revenues come from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience and metabolics. Regional commercial organizations are used to distribute and sell the product. The business is also supported by global corporate staff functions. These products are sold mainly to wholesalers, and to a lesser extent, directly to distributors, retailers, hospitals, clinics, government agencies and pharmacies. The Company’s key products include, Plavix, Avapro, Eliquis, Reyataz, Sustiva Franchise, Baraclude, Sprycel, Yervoy, Orencia among others.The Company promotes its products directly to healthcare providers such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs), Managed Care Organizations (MCOs) and government agencies. The Company also markets directly to consumers in the U.S. through direct-to-consumer print, radio and television and digital advertising and promotion. The markets in which the Company competes are generally broad-based and highly competitive. The Company competes with other research-based drug companies, many smaller research companies and generic drug manufacturers. The Company is subject to global regulation by regional, country, state and local agencies.lessless

                      Key People

                      Lamberto Andreotti

                      CEO/Director

                      James M. Cornelius

                      Director/Chairman of the Board

                      Mr. Charles A. Bancroft

                      CFO/Executive VP

                      Mr. Paul von Autenried

                      Chief Information Officer/Senior VP, Divisional

                      Mr. Francis M Cuss

                      Chief Scientific Officer/Executive VP

                      • Bristol-Myers Squibb Co

                      • 345 Park Avenue

                      • New York, NY 10154

                      • USA.Map

                      • Phone: +1 212 546-4000

                      • Fax: -

                      • bms.com

                      Incorporated

                      1933

                      Employees

                      28,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: